Literature DB >> 20186457

A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.

Satoshi Morimoto1, Nobuyuki Takahashi, Kazunori Someya, Tatsuyori Morita, Fusakazu Jo, Nagaoki Toyoda, Atsushi Kosaki, Mitsushige Nishikawa, Toshiji Iwasaka.   

Abstract

A 67-year-old woman was admitted to our hospital because of anasarca due to refractory nephrotic syndrome and chronic renal insufficiency. Laboratory data indicated serum total protein of 4.8 g/dl, albumin of 1.5 g/dl, creatinine of 1.9 mg/dl and BUN of 17 mg/dl. Urinary protein excretion was 7.8 g/day. Because of severe atrophy of both kidneys, neither renal biopsy nor immunosuppressive treatment was performed. Since conservative management including bed rest, diet therapy, limitation of water intake and administration of diuretics was not effective, peritoneal dialysis therapy using icodextrin only at night was started. The amount of water removal was steadily secured without progressing renal dysfunction or decreasing urine volume. From day 290 onward, the urinary protein excretion was decreased to show complete remission and urine volume increased. On day 528, peritoneal dialysis was discontinued, and thereafter only peritoneal lavage was performed. On day 858, the catheter was removed from the abdominal cavity, and thereafter diuretics could be discontinued. The reason for the dramatic reduction of urinary protein in this patient is unclear. However, it is possible that the primary disease such as membranous nephritis showed remission while the patient was undergoing icodextrin peritoneal dialysis, which preserves renal function but not extracorporeal ultrafiltration or hemodialysis. Icodextrin peritoneal dialysis may be an alternative to hemodialysis for refractory fluid overload in patients with nephrotic syndrome and may have the advantage of preserving renal function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186457     DOI: 10.1007/s10157-010-0271-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  Icodextrin with small and short dwell enhances ultrafiltration in peritoneal dialysis patients with severe overhydration.

Authors:  S Kuriyama; Y Otsuka; R Iida; K Matsumoto; T Hosoya
Journal:  Perit Dial Int       Date:  2006 Jul-Aug       Impact factor: 1.756

2.  Icodextrin preserves residual renal function in patients treated with automated peritoneal dialysis.

Authors:  Yoko Adachi; Yusuke Nakagawa; Akira Nishio
Journal:  Perit Dial Int       Date:  2006 May-Jun       Impact factor: 1.756

3.  "Icodextrin alone" for initiation of peritoneal dialysis.

Authors:  T K Jeloka
Journal:  Perit Dial Int       Date:  2008 Sep-Oct       Impact factor: 1.756

4.  Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.

Authors:  C Basile; D Chimienti; A Bruno; S Cocola; P Libutti; A Teutonico; F Cazzato
Journal:  Perit Dial Int       Date:  2009 Jan-Feb       Impact factor: 1.756

5.  The variability in ultrafiltration achieved with icodextrin, possibly explained.

Authors:  Daniele Venturoli; Tarun K Jeloka; Fevzi F Ersoy; Bengt Rippe; Dimitrios G Oreopoulos
Journal:  Perit Dial Int       Date:  2009 Jul-Aug       Impact factor: 1.756

6.  Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.

Authors:  B Rippe; L Levin
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

7.  A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.

Authors:  C D Mistry; R Gokal; E Peers
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

8.  Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange.

Authors:  Simon J Davies; Elvia Garcia Lopez; Graham Woodrow; Kieron Donovan; Jorg Plum; Paul Williams; Ann Catherine Johansson; Hans-Peter Bosselmann; Olof Heimburger; Ole Simonsen; Andrew Davenport; Bengt Lindholm; Anders Tranaeus; Jose C Divino Filho
Journal:  Nephrol Dial Transplant       Date:  2008-05-02       Impact factor: 5.992

9.  Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.

Authors:  C D Mistry; N P Mallick; R Gokal
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

10.  Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.

Authors:  N Posthuma; P M ter Wee; A J Donker; P L Oe; W van Dorp; E M Peers; H A Verbrugh
Journal:  Perit Dial Int       Date:  1997 Nov-Dec       Impact factor: 1.756

View more
  2 in total

1.  Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.

Authors:  Daisuke Takada; Akiko Mii; Seiichiro Higo; Yoshihiro Obara; Yuichi Kurabayashi; Norio Kurosawa; Shiro Miura; Hiroshi Kawachi; Akira Shimizu
Journal:  CEN Case Rep       Date:  2012-04-25

2.  Peritoneal dialysis outcomes in patients with nephrotic syndrome: a propensity score-matched cohort study.

Authors:  Si-Jia Zhou; Ya-Kun Cong; Qing-Feng Han; Wen Tang; Tao Wang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.